LEFFORD M
Immunology. 1980; 41(3):635-42.
PMID: 7461705
PMC: 1458132.
Senyk G, Sharp M, Stites D, Hanna L, Keshishyan H, JAWETZ E
Med Microbiol Immunol. 1980; 168(2):91-101.
PMID: 7005642
DOI: 10.1007/BF02121757.
Mokhtarian F, Griffin D, Hirsch R
Infect Immun. 1982; 35(3):965-73.
PMID: 6279519
PMC: 351142.
DOI: 10.1128/iai.35.3.965-973.1982.
Dimitriu A, Dy M, Thomson N, Bona C
Clin Exp Immunol. 1974; 18(1):141-8.
PMID: 4619594
PMC: 1537970.
Glade P, Papageorgiou P
In Vitro. 1973; 9(3):202-15.
PMID: 4591730
DOI: 10.1007/BF02618438.
Differential effects of immunosuppressants on lymphocyte function.
Winkelstein A
J Clin Invest. 1973; 52(9):2293-9.
PMID: 4542235
PMC: 333033.
DOI: 10.1172/JCI107417.
On the relation of products of activated lymphocytes to cell-mediated cytolysis.
Henney C, Gaffney J, Bloom B
J Exp Med. 1974; 140(3):837-52.
PMID: 4370241
PMC: 2139607.
DOI: 10.1084/jem.140.3.837.
Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
Pick E
Immunology. 1974; 26(3):649-58.
PMID: 4369184
PMC: 1423207.
Enumeration of activated thymus-derived lymphocytes by the virus plaque assay.
Kano S, Bloom B, Howe M
Proc Natl Acad Sci U S A. 1973; 70(8):2299-303.
PMID: 4365371
PMC: 433722.
DOI: 10.1073/pnas.70.8.2299.
The mediator of cellular immunity. VII. Localization of sensitized lymphocytes in inflammatory exudates.
McGregor D, Logie P
J Exp Med. 1974; 139(6):1415-30.
PMID: 4208417
PMC: 2139683.
DOI: 10.1084/jem.139.6.1415.
Production of macrophage migration inhibition factors by virus-infected cell cultures.
Flanagan T, Yoshida T, Cohen S
Infect Immun. 1973; 8(2):145-50.
PMID: 4199152
PMC: 422825.
DOI: 10.1128/iai.8.2.145-150.1973.
Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole.
Daniels J, Fajardo I, David J
Proc Natl Acad Sci U S A. 1975; 72(11):4569-72.
PMID: 1105584
PMC: 388764.
DOI: 10.1073/pnas.72.11.4569.
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.
Balow J, Hurley D, Fauci A
J Clin Invest. 1975; 56(1):65-70.
PMID: 1095612
PMC: 436556.
DOI: 10.1172/JCI108080.
Characterization of dextran-activated T-cell factors.
Alevy Y, BATTISTO J
Immunology. 1976; 30(3):391-9.
PMID: 1082853
PMC: 1445164.
Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.
Winkelstein A
J Clin Invest. 1975; 56(6):1587-96.
PMID: 1081551
PMC: 333138.
DOI: 10.1172/JCI108241.
Antigen-binding T and B lymphocytes in sensitization and unresponsiveness to dinitrochlorobenzene (DNCB) contact sensitivity.
Polak L, Ryden A, Roelants G
Immunology. 1975; 28(3):479-84.
PMID: 1079198
PMC: 1445788.
Serum immunoglobulin, dermal response, and lymphocyte transformation studies in horses with chronic diarrhea.
Targowski S
Infect Immun. 1975; 12(1):48-54.
PMID: 806535
PMC: 415243.
DOI: 10.1128/iai.12.1.48-54.1975.
Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
Kondo H, Rabin B, Rodnan G
J Clin Invest. 1976; 58(6):1388-94.
PMID: 791970
PMC: 333310.
DOI: 10.1172/JCI108594.
Effect of immunosuppressive drugs on an in vito correlate of cell-mediated immunity. The migration inhibition test.
PEKAREK J, SVEJCAR J, Nouza K, JOHANOVSKY J
Immunology. 1976; 31(5):773-9.
PMID: 791852
PMC: 1445132.
Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes.
Senik A, Bloom B
J Exp Med. 1977; 146(1):11-21.
PMID: 194999
PMC: 2180746.
DOI: 10.1084/jem.146.1.11.
